[Estimation of cardiac vagal reserve by dynamic exercise in patients with recent myocardial infarction]. / Estimacícon de la reserva cardiaca vagal mediante el ejercicio dinámico en pacientes con infarto miocárdico reciente.

In patients with coronary artery disease, the risk of sudden death is related to the degree of left ventricular dysfunction and to cardiac parasympathetic activity. The relation between these two consequences of myocardial infarction is still the matter of intense controversy. In this investigation, we have estimated the resting cardiac parasympathetic tone and assessed the left ventricular systolic function of 25 patients who had suffered an acute myocardial infarction. The absolute increase in heart rate recorded in the first 10 seconds of a programmed dynamic exercise, was considered as the resting cardiac parasympathetic tone or cardiac parasympathetic reserve. Twenty five age and sex-matched normal sedentary subjects were used as controls. Patients showed a significantly smaller increase in their heart rate (16 +/- 4 lats/min, M +/- DS) than the controls 32 +/- 5 P < 0.0001), during the first 10 seconds of exercise. Moreover, the absolute increase in heart rate was inversely related to the degree of left ventricular dilatation ( r = - 0.71, P < 0.0001) and directly related to the left ventricular ejection fraction (r = 0.84, P < 0.0001). In other words, those patients with larger left ventricles and depressed ventricular function had a more prominent reduction of their resting cardiac parasympathetic tone. These results indirectly suggest that, left ventricular size and function are indeed related to cardiac parasympathetic activity.

Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure.

Chagasic patients with congestive heart failure are usually treated with digitalis and converting enzyme inhibitors. According to the neurogenic and dysautonomic theories, chagasic patients would not benefit from these drugs. To clarify this controversial issue, we have studied patients with congestive heart failure and suspected Chagas' heart disease. All patients received intravenous methyl-digoxin for 24 h and oral enalapril for 96 h. Blood samples for plasma norepinephrine, aldosterone and renin were taken at baseline, after acute digitalization and following enalapril. Based on the serology for Chagas' disease, the patients were divided into non-chagasic and chagasic patients. In the chagasic group three patients were in functional class III and 3 were in functional class IV. In the non-chagasic group five patients were in functional class III and 2 were in functional class IV. Both groups had a marked and quantitatively similar degree of neurohormonal activation. All patients improved at least one functional class and lost more than 5 kg of body weight with treatment. The chagasic patients had a statistically significant reduction in plasma norepinephrine (2262 +/- 1407 to 865 +/- 390, P < 0.008, pg/ml, M +/- S.D.), plasma aldosterone (330 +/- 168 to 155 +/- 75, P < 0.01, pg/ml, M +/- S.D.) and plasma renin activity (14 +/- 13 to 2 +/- 1.6 ng/ml per h, M +/- S.D., P < 0.05), with digitalis. Following enalapril, norepinephrine and aldosterone there was a further but non-significant reduction, when compared to postdigitalis values. These results indicated that chagasic patients do benefit from digitalis and enalapril. Furthermore, the prominent and significant reduction in all three neurohormones suggest that the parasympathetic and sympathetic systems of these chagasic and non-chagasic patients, are responding to the neuromodulatory effects of digitalis and enalapril.

Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease.

The functional status of the sympathetic nervous system in Chagas' heart disease is still the subject of intense controversy. To determine the nature of the abnormalities of the sympathetic nervous system, we measured the plasma norepinephrine concentration of chagasic patients with varying degrees of myocardial damage. Thirty-six patients with positive serology for Chagas' disease were studied. Twenty patients were in Functional Class I (New York Heart Association), 10 were in Functional Class II and six were in Functional Classes III-IV. Cardiac catheterization was performed in 24 patients. The asymptomatic patients had a plasma norepinephrine concentration (121 +/- 37 pg/ml, mean +/- S.D.) not different from normal controls (103 +/- 59 pg/ml). The symptomatic patients, however, had a significantly elevated plasma norepinephrine concentration (665 +/- 354 pg/ml, P < 0.001). The baseline heart rate of the asymptomatic and symptomatic patients directly correlated with the plasma norepinephrine concentration (r = 0.69, P < 0.0001). The symptomatic patients had larger ventricular volumes, higher left ventricular end-diastolic pressures and lower ejection fractions than the asymptomatic patients and normal controls. The plasma norepinephrine concentration correlated linearly with the left ventricular end-diastolic volume (r = 0.77, P < 0.0001), and non-linearly with the ejection fraction (r = -0.70, P < 0.0001) and the left ventricular end-diastolic pressure (r = 0.53, P < 0.007). These results indicate that, in Chagas' heart disease as in most other cardiac diseases, sympathetic nervous system activation is a late and compensatory phenomenon. In other words, sympathetic activation is very likely related to the progressive impairment of left ventricular function.